Navigation Links
MedQuist Reports Third Quarter 2008 Results
Date:11/4/2008

MOUNT LAUREL, N.J., Nov. 4 /PRNewswire-FirstCall/ -- MedQuist Inc. (Nasdaq: MEDQ), the largest Medical Transcription Service Organization (MTSO) in the world, today announced its results for the quarter ended September 30, 2008.

Net revenues for the third quarter of 2008 were $81.3 million compared with $82.5 million in the third quarter of 2007. The decrease in net revenues of $1.2 million or 1% from the prior year period was driven primarily by lower average pricing.

The operating loss for the quarter improved to a loss of $5.3 million compared to an operating loss of $10.3 million in the third quarter of 2007. The current period operating loss includes a charge of $5.9 million related to a tentative settlement of the Department of Justice's (DOJ) investigation of the company. The DOJ and the company have reached a tentative agreement to settle the DOJ's civil investigation for a payment of $6.8 million of which $0.9 million was previously recorded. Non-GAAP operating income (excluding the cost of investigation and legal proceedings, net) improved by $7.8 million to a profit of $1.9 million in the third quarter of 2008 compared to a non-GAAP operating loss of $5.9 million in the third quarter of 2007.

Cost of revenues were reduced by $7.1 million or 11% to $57.2 million in the third quarter of 2008 compared to $64.3 million in the third quarter of 2007. This resulted in a decrease in cost of revenues as a percentage of net revenues to 70% compared to 78% in the third quarter of 2007.

Selling general and administrative expenses declined $2.4 million or 15% to $13.1 million in the third quarter of 2008 compared to $15.5 million in the third quarter of 2007. This decline primarily reflects the benefits of the re
'/>"/>

SOURCE MedQuist Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. MedQuist Reports Second Quarter 2008 Results
2. MedQuist Announces Changes to Board of Directors
3. MedQuist Announces Declaration of $2.75 per share Dividend on Common Stock
4. Award-Winning Massachusetts Hospital Selects MedQuist Enterprise Technology for Clinical Documentation and Speech Recognition
5. MedQuist Announces Dismissal of South Broward Litigation and Appointment of New Interim President & CEO
6. MedQuist to Get New Majority Stakeholder
7. MedQuist Technology Solutions to Power Documentation Workflow at New England Facility
8. MedQuist Announces Entry Into Settlement Term Sheet Resolving South Broward Litigation
9. Leading Arizona Radiological Group Selects MedQuist for Speech Recognition Solution
10. MedQuist Announces Appointment of Brian ODonoghue and Mark E. Schwarz to its Board of Directors
11. MedQuist Files Preliminary Proxy Statement and Applies for Listing on NASDAQ
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... 2014 Best Cheap Hosting USA is ... The site has recently announced that iPower ( http://www.best-cheap-hosting-usa.com/go/iPower/ ... people from around the world. , “iPower is one ... and is providing various kinds of useful products for ... on offering excellent customer service and a number of ...
(Date:10/22/2014)... Although there are only 24 hours in a ... who have trouble finding time within their busy schedules for exercise ... periods of time to get in shape. Here are five ways ... go. , Change Up Your Commute , Consider riding a ... some exercise into your daily routine. If you must use your ...
(Date:10/22/2014)... WALTHAM, MA (PRWEB) October 22, 2014 ... developing new solutions for the treatment of bacterial infections, ... J. Sinskey has joined its board of directors. ... Microbiology and Engineering Systems at The Massachusetts Institute of ... the MIT faculty since 1968. Dr. Sinskey also holds ...
(Date:10/22/2014)... -- Two sisters in high school have developed ways ... Medha Krishen use electronic stethoscopes, which electronically amplify body ... patterns or heartbeats. Ilina, a senior at Port ... a way to detect early lung damage in people ... Ilina recorded one breath cycle each from 16 smokers, ...
(Date:10/22/2014)... Oct. 21, 2014 (HealthDay News) -- Measures taken by ... in Ebola-ravaged Liberia may have limited the spread of ... report. The Firestone Natural Rubber Co. provides health ... residents of nearby densely populated communities. Between Aug. ... suspected Ebola cases among those 80,000 people. That incidence ...
Breaking Medicine News(10 mins):Health News:Best Cheap Hosting USA Has Recently Announced The Best Cheap Web Hosting Companies In 2014 2Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2
... The Childrens Report of Sleep Patterns (CRSP), a ... and sleep disturbances for school-aged children, may be a ... hygiene, and sleep disturbances in children eight to 12 ... will be presented on Wednesday at SLEEP 2008, the ...
... Among the Top Healthcare IT Providers Underscores Cognizant,s ... in the Healthcare and Life Sciences Industry, ... leading provider of global consulting, technology and business,process ... ranked the 11th,largest healthcare IT provider by Healthcare ...
... For the first time, UCLA researchers have discovered that ... regions that help store memory. Reported in the June ... emphasize the importance of early detection of the disorder, ... , Sleep apnea occurs when a blocked airway ...
... Team of Physicians Give Manuel ... Uribe A New Lease on Life, DANVERS, Mass., June 10 ... man in the world, has,lost more than one-third of his body weight and ... by Dr. Barry Sears,creator of the Zone Diet. As he approaches his 43rd ...
... XL Capital Ltd,(NYSE: XL ) (the "Company") ... judgment handed down by the U.S. District Court for ... Lynch International. Merrill Lynch,International filed a complaint against Security ... Assurance Inc. (XLCA), relating to,certain credit default swap transactions ...
... effects of biomarkers most promising way,to help older ... 10 The Kronos Longevity,Research Institute (KLRI) has ... "the vicious triad" of the aging process: oxidative ... age-related,deteriorations and diseases. Longevity scientists across the country ...
Cached Medicine News:Health News:'Children's Report of Sleep Patterns' a reliable, maybe a valid measure of children's sleep habits 2Health News:Cognizant Ranks #11 on Healthcare Informatics 100 List 2Health News:Cognizant Ranks #11 on Healthcare Informatics 100 List 3Health News:Memory loss linked to common sleep disorder 2Health News:Memory loss linked to common sleep disorder 3Health News:Video: World's Heaviest Man Celebrates Birthday and Weight Loss Milestone 2Health News:Video: World's Heaviest Man Celebrates Birthday and Weight Loss Milestone 3Health News:XL Capital Ltd Issues Statement Regarding Merrill Lynch Lawsuit Against XL Capital Assurance Inc. (XLCA) a Subsidiary of Security Capital Assurance Ltd 2Health News:New KLRI Reports Shows Longevity Science Moving Beyond Studying the Obvious to the 'Downward Spiral' Paradigm in the Aging Process 2Health News:New KLRI Reports Shows Longevity Science Moving Beyond Studying the Obvious to the 'Downward Spiral' Paradigm in the Aging Process 3
(Date:10/22/2014)... Oct. 22, 2014   Surefire Medical , Inc., ... designed to maximize targeted delivery of embolization agents in ... that oncologist John R. Daniels , MD of ... and surgical oncologist Steven C. Katz , MD ... Company,s Scientific Advisory Board (SAB).    "The ...
(Date:10/22/2014)... and AUSTIN, Texas , Oct. ... LLC today announced they have entered into a ... immunotherapies designed to target cancers. PhosImmune ... displayed on the surfaces of tumor cells in ... (PTTs), derived from proteins that play a role ...
(Date:10/22/2014)... Calif. , Oct. 22, 2014 /PRNewswire/ ... ), a biopharmaceutical company leading the discovery ... today announced that it has demonstrated human ... ongoing clinical study evaluating RG-101, a wholly-owned, ... treatment of hepatitis C virus infection ("HCV").  ...
Breaking Medicine Technology:Surefire Medical's Scientific Advisory Board Expands, Broadens Clinical Trial Expertise 2Biotech Companies To Co-Discover And Co-Develop Antibodies Targeting Novel Phosphopeptide Tumor Targets 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8
... Medical Hematology and Oncology CHU Lapeyronie, Montpellier ... that has long been recognized as a marker ... range of diagnostic markers to monitor infection and ... a necessity throughout the health care sector, it ...
... ,Since the first system was invented in 1957, ... patient care. During the 1960s, blood gas analysis ... considered "the most important laboratory test for critically ... Dr. John Severinghaus, inventor of the blood gas ...
Cached Medicine Technology:Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing 2Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing 3Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing 4Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing 2Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing 3Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing 4
... Dengue virus belongs to the Flavavirus group ... throughout the tropics.,Symptoms of Dengue fever are ... in the back and limbs, lymphadenopathy,maculopapular rash ... professional use as an aid in the ...
... The Dengue virus belongs to the Flavavirus ... commonly throughout the tropics.,Symptoms of Dengue fever ... pain in the back and limbs, lymphadenopathy,maculopapular ... for professional use as an aid in ...
The IntraStent DoubleStrut Biliary Stent represents a completely new direction in stent design. The combination of parallel struts and unique cell geometry provide unparalleled performance....
For the rapid determination of human chorionic gonadotropin (hCG) in urine. The test strip is used to obtain a visual qualitative result....
Medicine Products: